pSIT (ATCC® 87064)

Applications: expression vectorvector permitting RNA synthesis in vitrovector permitting production of single-stranded DNAvector useful for site-directed mutagenesis  /  Depositors: E Hunter

Permits and Restrictions

View Permits

Designations pSIT
Depositors E Hunter
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Vector Information
Size (kb): 6.0999999046325680
Vector: pSIT (phagemid)
Promoters: Promoter T7 (phi10)
Construction: pSELECT, T7 promoter (pET-11d)
Construct size (kb): 6.099999904632568
Features: initiation codon: ATG
marker(s): ampS
marker(s): tetR
operator: lac
promoter: T7 (phi10)
replicon: f1
replicon: pMB1
repressor gene: lacIq
restriction site: BamHI
restriction site: EspI
restriction site: NcoI
ribosome-binding site: T7 (phi10)
terminator: T7 (phi10)
expression vector
vector permitting RNA synthesis in vitro
vector permitting production of single-stranded DNA
vector useful for site-directed mutagenesis
Restriction digests of the clone give the following sizes (kb): BamHI--6.1; XbaI--6.1; EcoRV--4.35, 1.75.
Vector contains the following restriction sites (approximate kb from nt 1): BamHI--0.14; BglI--1.40, 1.63, 4.47, 4.59, 6.04; ClaI--0.49; EcoRV--0.65, 2.40; NcoI--0.11; PvuI--1.86, 4.72, 6.07; PvuII--1.89, 2.16, 2.25; XbaI--0.07.
Mutagenesis is achieved through alkali denaturation of the plasmid containing a cloned insert, followed by amplification of the plasmid using an ampicillin repair primer and a mutagenic primer.
Single stranded DNA can also be generated by infection with a helper phage such as R408 or M13K07 (ATCC 37468).
Following in vitro synthesis of the second DNA strand, the plasmid should be grown in E. coli BMH 71-18 mutS or ES1301 mutS (to avoid repair of the mutation) and can be selected for ampicillin resistance.
Clones can then be transformed into a suitable strain for propagation (E. coli JM109 - ATCC 53323) or expression (E. coli BL21 (DE3)).
Several rounds of mutation can be achieved by including a tetracycline inactivation primer in the first round, so that tetracycline resistance can be restored and used as a marker for second round mutants.
Best mutagenic efficiency was achieved using a 10 fold molar excess of mutagenic primer to ampicillin repair primer.
Expression vector allowing site directed mutagenesis of cloned inserts and subsequent selection of mutants for ampicillin resistance.
The following oligonucleotides can be used to repair or inactivate the vector markers: ampicillin repair, 5'-GTTGCCATTGCTGCAGGCATCGTGGTG-3'; ampicillin knockout, 5'-GTTGCCATTGCGGCATCGTGGTGTCAC-3'; tetracyclin repair, 5'-GCCGGGCCTCTTGCGGGATATCGTCCA-3';
tetracycline knockout, 5'-GCCGGGCCTCTTGCGGGCGTCCATTCC-3'.
Constructed from pSELECT by replacing the lacZ region with a T7 promoter, under control of the lac repressor, and replacing the rop copy number control sequence with the lacIq repressor gene.
Media ATCC® Medium 1273: LB medium (ATCC medium 1065) with 20 mcg/ml tetracycline
Growth Conditions
Temperature: 37.0°C

Andreansky M, Hunter E. Phagemid pSIT permits efficient in vitro mutagenesis and tightly controlled expression in E. coli. BioTechniques 16: 626-633, 1994. PubMed: 8024782

Shipped freeze-dried
Product Sheet
Product Sheet
Product Sheet
Attachments Vector Map